High urgency

What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - Reed Smith LLP

Detected July 28, 2026 · in Pharmacy & Controlled Substances

DEA proposes a special registration framework for tele-prescribing controlled substances, which would allow practitioners to prescribe schedule II-V controlled substances via telemedicine without an in-person exam, subject to conditions.

Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 28, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies should confirm how it applies to their specific situation before acting. There is a time constraint attached: Proposed rule comment period likely 60-90 days from publication; final rule effective date TBD.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

DEA proposes a new special registration for tele-prescribing controlled substances, potentially expanding telemedicine prescribing of controlled substances beyond current emergency flexibilities.

Who it affects

Independent pharmacies, retail chains, compounding pharmacies, long-term-care pharmacies

What you must do

Monitor rulemaking and prepare to comply with new registration requirements for tele-prescribing controlled substances.

Deadline

Proposed rule comment period likely 60-90 days from publication; final rule effective date TBD.

Source: https://news.google.com/rss/articles/CBMi-wFBVV95cUxPeFpzVHVTZTJLNEdhT3RhRy00c09kN21zTmwzQm9YSHJPLXRmbGxmWWphVjlkckRXdTRWRTVNZURhV2pIcDhBR0hKSmRKZFluSDZrYjBaZndEYThqWDljNG1Rd0kybjVUdDNfMkRadnRnZE5Dd0JORGk0dVJKbUZibXlNUEpKeVFJbXc1dWZRb29jZ3JqbE1OQ0QtS0NNaVpMR2ZzaFV3Mk4xSDZtVnJlaGlQNlRiQ2lwdW1MQW1hTy1hdV9jTDBSNHNWYWV4bjZ3VUlGZVZ1Qlg5WmhLcGpVa0h3QndZLWl2cVFDSzZBb0MwTkFOZlhLQVA3Yw?oc=5

Never miss a change like this again

Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Pharmacy & Controlled Substances